News Release

 View printer-friendly version «  Back
April 30, 2002 at 10:43 PM EDT

CONMED Corporation Files Registration Statement for Common Stock Offering

UTICA, N.Y., Apr 30, 2002 /PRNewswire-FirstCall via COMTEX/ -- CONMED Corporation (Nasdaq: CNMD) announced today that it filed a registration statement with the Securities and Exchange Commission in connection with a primary offering by the Company of 3,000,000 shares of its common stock.

Salomon Smith Barney Inc. and UBS Warburg LLC are acting as managing underwriters of the offering.

CONMED is a medical technology company specializing in instruments, implants, and video equipment for arthroscopic sports medicine, and powered surgical instruments, such as drills and saws, for orthopedic, ENT, neuro-surgery, and other surgical specialties. The Company is also a leading developer, manufacturer and supplier of advanced surgical devices, including radio frequency, or RF, electrosurgery systems used routinely to cut and cauterize tissue in nearly all types of surgical procedures worldwide, and endoscopy products such as trocars, clip appliers, scissors, and surgical staplers. The Company also manufactures and sells a full line of ECG electrodes for heart monitoring and other patient care products. Headquartered in Utica, New York, the Company's 2,500 employees distribute its products worldwide from eight manufacturing locations.

A registration statement relating to the common stock has been filed with the Securities and Exchange Commission but has not yet become effective. The common stock may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

                    MAKE YOUR OPINION COUNT -  Click Here
               http://tbutton.prnewswire.com/prn/11690X28898667
SOURCE CONMED Corporation

CONTACT:          Robert Shallish of CONMED Corporation, Chief Financial Officer,
                  +1-315-624-3206; Investors - Theresa Vogt or Lanie Fladell, or Media - Dan
                  Budwick, +1-212-850-5600, all of Morgen-Walke Associates, for CONMED
                  Corporation
                  /Company News On-Call:  http://www.prnewswire.com/comp/201850.html

URL:              http://www.conmed.com
http://www.prnewswire.com
Copyright (C) 2002 PR Newswire.  All rights reserved.